IT8921339A0 - Composizione farmaceutica per uso orale contenente nac. - Google Patents

Composizione farmaceutica per uso orale contenente nac.

Info

Publication number
IT8921339A0
IT8921339A0 IT8921339A IT2133989A IT8921339A0 IT 8921339 A0 IT8921339 A0 IT 8921339A0 IT 8921339 A IT8921339 A IT 8921339A IT 2133989 A IT2133989 A IT 2133989A IT 8921339 A0 IT8921339 A0 IT 8921339A0
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
oral use
use containing
containing nac
nac
Prior art date
Application number
IT8921339A
Other languages
English (en)
Other versions
IT1231012B (it
Inventor
Angelo Carenzi
Dario Chiarino
Antonio Longo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of IT8921339A0 publication Critical patent/IT8921339A0/it
Priority to IT8921339A priority Critical patent/IT1231012B/it
Priority to IE262790A priority patent/IE902627A1/en
Priority to CH2424/90A priority patent/CH680190A5/it
Priority to IL95158A priority patent/IL95158A0/xx
Priority to CA002021808A priority patent/CA2021808A1/en
Priority to GB9016256A priority patent/GB2234171B/en
Priority to GR900100569A priority patent/GR900100569A/el
Priority to ZA905861A priority patent/ZA905861B/xx
Priority to NZ234647A priority patent/NZ234647A/en
Priority to JP2197575A priority patent/JPH0399012A/ja
Priority to FR909009493A priority patent/FR2650503B1/fr
Priority to SE9002500A priority patent/SE9002500L/xx
Priority to BE9000746A priority patent/BE1003188A4/fr
Priority to DE4023774A priority patent/DE4023774A1/de
Priority to DK177890A priority patent/DK177890A/da
Priority to FI903759A priority patent/FI903759A0/fi
Priority to KR1019900011440A priority patent/KR910002438A/ko
Priority to NL9001714A priority patent/NL9001714A/nl
Priority to AU59935/90A priority patent/AU625925B2/en
Priority to US07/558,672 priority patent/US5080906A/en
Application granted granted Critical
Publication of IT1231012B publication Critical patent/IT1231012B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8921339A 1989-07-27 1989-07-27 Composizione farmaceutica per uso orale contenente nac. IT1231012B (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT8921339A IT1231012B (it) 1989-07-27 1989-07-27 Composizione farmaceutica per uso orale contenente nac.
IE262790A IE902627A1 (en) 1989-07-27 1990-07-18 Pharmaceutical composition for oral administration¹containing nac
CH2424/90A CH680190A5 (it) 1989-07-27 1990-07-20
IL95158A IL95158A0 (en) 1989-07-27 1990-07-23 Pharmaceutical composition for oral administration containing n-acetyl-cysteine
CA002021808A CA2021808A1 (en) 1989-07-27 1990-07-24 Pharmaceutical composition for oral administration containing nac
FR909009493A FR2650503B1 (fr) 1989-07-27 1990-07-25 Composition pharmaceutique destinee a etre administree par voie orale et contenant de la n-acetyl-cysteine, et son application
GR900100569A GR900100569A (el) 1989-07-27 1990-07-25 Μέ?οδος παρασκευής ενώσεως για χορήγηση δια του στόματος περιεχούσης NAC.
ZA905861A ZA905861B (en) 1989-07-27 1990-07-25 Pharmaceutical composition for oral administration containing nac
NZ234647A NZ234647A (en) 1989-07-27 1990-07-25 Oral pharmaceutical compositions containing n-acetyl cysteine and tris(hydroxymethyl)aminomethane
JP2197575A JPH0399012A (ja) 1989-07-27 1990-07-25 経口投与可能なｎ―アセチル―システイン含有製剤
GB9016256A GB2234171B (en) 1989-07-27 1990-07-25 N-Acetyl-cysteine compositions of enhanced bioavailability
DK177890A DK177890A (da) 1989-07-27 1990-07-26 Farmaceutisk praeparat indeholdende n-acetylcystein til oral indgivelse
BE9000746A BE1003188A4 (fr) 1989-07-27 1990-07-26 Composition pharmaceutique destinee a etre administree par voie orale et contenant de la n-acetyl-cysteine, et son application.
DE4023774A DE4023774A1 (de) 1989-07-27 1990-07-26 N-acetylcystein enthaltende, oral verabreichbare pharmazeutische zusammensetzung
SE9002500A SE9002500L (sv) 1989-07-27 1990-07-26 Farmaceutisk, nac-innehaallande komposition foer oral administrering
FI903759A FI903759A0 (fi) 1989-07-27 1990-07-27 Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.
KR1019900011440A KR910002438A (ko) 1989-07-27 1990-07-27 N-아세틸 시스테인 (nac)을 갖는 경구투여용 약리학적 조성물
NL9001714A NL9001714A (nl) 1989-07-27 1990-07-27 Farmaceutisch prepraat voor orale toediening bevattende nac.
AU59935/90A AU625925B2 (en) 1989-07-27 1990-07-27 Pharmaceutical composition for oral administration containing n-acetyl-cysteine and trihydroxy methylamino methane
US07/558,672 US5080906A (en) 1989-07-27 1990-07-27 Method and composition for oral administration of n-acetylcysteine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8921339A IT1231012B (it) 1989-07-27 1989-07-27 Composizione farmaceutica per uso orale contenente nac.

Publications (2)

Publication Number Publication Date
IT8921339A0 true IT8921339A0 (it) 1989-07-27
IT1231012B IT1231012B (it) 1991-11-08

Family

ID=11180335

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8921339A IT1231012B (it) 1989-07-27 1989-07-27 Composizione farmaceutica per uso orale contenente nac.

Country Status (20)

Country Link
US (1) US5080906A (it)
JP (1) JPH0399012A (it)
KR (1) KR910002438A (it)
AU (1) AU625925B2 (it)
BE (1) BE1003188A4 (it)
CA (1) CA2021808A1 (it)
CH (1) CH680190A5 (it)
DE (1) DE4023774A1 (it)
DK (1) DK177890A (it)
FI (1) FI903759A0 (it)
FR (1) FR2650503B1 (it)
GB (1) GB2234171B (it)
GR (1) GR900100569A (it)
IE (1) IE902627A1 (it)
IL (1) IL95158A0 (it)
IT (1) IT1231012B (it)
NL (1) NL9001714A (it)
NZ (1) NZ234647A (it)
SE (1) SE9002500L (it)
ZA (1) ZA905861B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
US5286480A (en) * 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
CA2276183C (en) 1996-12-31 2009-06-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
FR2803720B1 (fr) * 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
US6114387A (en) * 2000-02-16 2000-09-05 Cutler; Paul Pharmaceutical composition for oral administration of chelating agents
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
US20030162732A1 (en) * 2001-07-05 2003-08-28 Astion Development A/S Combination of aminosugars and cysteine or cysteine derivatives
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20021881A1 (it) * 2002-09-04 2004-03-05 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
KR20050104152A (ko) * 2004-04-28 2005-11-02 최승호 경구용 약물의 흡수를 증진하는 약제학적 조성물
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
PL3554491T3 (pl) * 2016-12-15 2023-07-17 Zambon S.P.A. N-acetylocysteina do stosowania jako środek antybakteryjny
WO2020021324A1 (en) * 2018-07-27 2020-01-30 I.C.F. Srl Compositions for the prevention and treatment of cutaneous affections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
US4894225A (en) * 1987-03-02 1990-01-16 Cetus Corporation Combination therapy using antitumor immunotoxins with tumor necrosis factor
JPS63290824A (ja) * 1987-05-22 1988-11-28 Sumitomo Chem Co Ltd ウイルス感染症治療剤
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina

Also Published As

Publication number Publication date
GB2234171B (en) 1993-11-10
SE9002500L (sv) 1991-01-28
ZA905861B (en) 1991-07-31
DK177890D0 (da) 1990-07-26
AU625925B2 (en) 1992-07-16
DE4023774A1 (de) 1991-01-31
CH680190A5 (it) 1992-07-15
GB9016256D0 (en) 1990-09-12
CA2021808A1 (en) 1991-01-28
IE902627A1 (en) 1991-02-27
FR2650503A1 (fr) 1991-02-08
IT1231012B (it) 1991-11-08
US5080906A (en) 1992-01-14
BE1003188A4 (fr) 1992-01-07
GB2234171A (en) 1991-01-30
FI903759A0 (fi) 1990-07-27
JPH0399012A (ja) 1991-04-24
SE9002500D0 (sv) 1990-07-26
AU5993590A (en) 1991-01-31
NZ234647A (en) 1992-02-25
KR910002438A (ko) 1991-02-25
IL95158A0 (en) 1991-06-10
NL9001714A (nl) 1991-02-18
FR2650503B1 (fr) 1992-05-29
GR900100569A (el) 1991-12-10
DK177890A (da) 1991-01-28

Similar Documents

Publication Publication Date Title
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A (fi) Farmaceutiska kompositioner.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE68901492D1 (de) Orale zusammensetzungen.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
DE69006094T2 (de) Pharmazeutische Zusammensetzungen.
DE68902629T2 (de) Orale zusammensetzung.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
FI893643A0 (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI872733A (fi) Farmaceutiska kompositioner.
FI872313A (fi) Farmaceutiska kompositioner.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT8919172A0 (it) Composizioni contenenti bismuto idonee per uso terapeutico.
IT8521214A0 (it) Composizione farmaceutica solida per uso orale.
DE69002865T2 (de) Orale Zubereitung.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
IT8621695A0 (it) Preparazione farmaceutica per uso veterinario.
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970612